Surgical Oncology Division
Surgery is an essential part of the treatment for patients with many types of cancer. Achieving the best results, however, often requires the coordinated efforts of an interdisciplinary team. Surgical Oncologists are uniquely trained not only in the techniques of cancer surgery, but also in how surgery fits in to the big picture of cancer care. Rather than viewing surgical procedures in isolation, surgical oncologists consider operations within the context of treatment plans that may incorporate chemotherapy, radiation therapy, and/or alternative approaches before, during, and after surgery. The Division of Surgical Oncology has established strong collaborative disease management programs with the other cancer-related disciplines at Mount Sinai in order to offer patients with a wide array of cancers the best chance for cure.
Education is an essential part of the mission of our Division. Interdisciplinary cancer conferences in breast, liver, pancreatic, biliary, and gastrointestinal malignancy are held on a weekly basis. These conferences serve an important role in educating the many students, residents, and fellows who come to Mount Sinai to learn about our approach to cancer care. Even more important, from the patients’ perspective, these conferences are the forum where our cancer team plans the management of complex cases, reviews the results of surgery and determines the need for additional postoperative treatment, and considers patients for whom effective standard therapy is not available for entry into clinical trials.
Because surgery, while the best treatment available, does not yet offer a sure cure for many patients with cancer, an active program of clinical and translational research, bringing the newest promising developments from our laboratories to our patients in need, is integral to our Division of Surgical Oncology. Studies in early cancer detection, tumor markers, cancer genetics, environmental risk factors, minimally invasive surgical techniques, nonsurgical tumor ablation, downstaging of advanced cancer to allow for surgical resection, transplantation for tumors, anesthesia for cancer surgery, adjuvant treatment to prevent cancer recurrence, tumor vaccines, gene therapy, and non-chemotherapy treatment of advanced cancer are ongoing in our Division, funded by the National Institutes of Health, the National Surgical Adjuvant Breast and Bowel Project, and our many partners in industry.
Mount Sinai Surgical Associates
Division of Surgical Oncology
1470 Madison Ave, 3rd Fl
New York, NY 10029